POAS

Phaos Technology Holdings (Caym

Price Chart

No historical data available

Latest Quote

$0.23

-0.02 (-8.95%)

Current Price

Previous Close	$0.25
Open	$0.26
Day High	$0.29
Day Low	$0.21
Volume	349,833

Fetched: 2026-07-15T18:41:23

Stock Information

Note: Financial values converted from SGD to USD

Shares Outstanding	16.45M
Total Debt	$3.04M
Cash Equivalents	$84K
Revenue	$149K
Net Income	$-3.59M
Sector	Healthcare
Industry	Medical Devices
Market Cap	$3.76M
EPS (TTM)	$-0.27
Exchange	ASE

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Phaos Technology Holdings (Caym

Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.

📰 Latest News

No news articles available at the moment. Check back later for updates on POAS.

Period:

Income Statement (Annual)

Metric	2025-04-30	2024-04-30	2023-04-30
Revenue
Reconciled Cost Of Revenue	$101,021	$828,660	$414,603
Cost Of Revenue	$101,021	$828,660	$414,603
Total Revenue	$129,683	$1,455,914	$503,242
Operating Revenue	$129,683	$1,455,914	$503,242
Expenses
Interest Expense	$6,544	$33,670	$19,383
Total Expenses	$3,217,837	$3,301,389	$1,802,625
Rent Expense Supplemental	$110,322	$105,769	$78,979
Other Income Expense	$-882,147	$54,348	$29,088
Other Non Operating Income Expenses	$64,032	$54,348	$17,662
Net Non Operating Interest Income Expense	$-2,034	$-33,669	$-19,381
Interest Expense Non Operating	$6,544	$33,670	$19,383
Operating Expense	$3,116,816	$2,472,730	$1,388,022
Other Operating Expenses	$325,544	$126,241	$-14,496
Selling And Marketing Expense	$44,856	$67,281	$26,564
General And Administrative Expense	$2,493,802	$2,072,530	$1,203,827
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-3,972,335	$-1,824,796	$-1,289,677
Net Interest Income	$-2,034	$-33,669	$-19,381
Interest Income	$4,510	$2	$2
Normalized Income	$-3,026,157	$-1,824,796	$-1,301,103
Net Income From Continuing And Discontinued Operation	$-3,972,335	$-1,824,796	$-1,289,677
Total Operating Income As Reported	$-4,082,774	$-1,935,594	$-1,579,185
Net Income Common Stockholders	$-3,972,335	$-1,824,796	$-1,289,677
Net Income	$-3,972,335	$-1,824,796	$-1,289,677
Net Income Including Noncontrolling Interests	$-3,972,335	$-1,824,796	$-1,289,677
Net Income Continuous Operations	$-3,972,335	$-1,824,796	$-1,289,677
Pretax Income	$-3,972,335	$-1,824,796	$-1,289,677
Special Income Charges	$-946,179	$0	$11,426
Interest Income Non Operating	$4,510	$2	$2
Operating Income	$-3,088,154	$-1,845,475	$-1,299,384
Depreciation Amortization Depletion Income Statement	$144,573	$136,647	$151,283
Depreciation And Amortization In Income Statement	$144,573	$136,647	$151,283
Depreciation Income Statement	$144,573	$136,647	$151,283
Gross Profit	$28,662	$627,255	$88,638
Per Share
Diluted EPS	-	$-0.14	$-0.48
Basic EPS	-	$-0.14	$-0.48
Other
Tax Effect Of Unusual Items	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-2,875,040	$-1,654,478	$-1,130,437
Total Unusual Items	$-946,179	$0	$11,426
Total Unusual Items Excluding Goodwill	$-946,179	$0	$11,426
Reconciled Depreciation	$144,573	$136,647	$151,283
EBITDA (Bullshit earnings)	$-3,821,218	$-1,654,478	$-1,119,011
EBIT	$-3,965,791	$-1,791,125	$-1,270,294
Diluted NI Availto Com Stockholders	$-3,972,335	$-1,824,796	$-1,289,677
Tax Provision	$0	$0	$0
Gain On Sale Of Ppe	$0	$0	$11,426
Write Off	$946,179	$0	-
Research And Development	$108,041	$70,032	$20,844
Selling General And Administration	$2,538,658	$2,139,810	$1,230,391
Other Gand A	$479,438	$534,688	$88,205
Rent And Landing Fees	$110,322	$105,769	$78,979
Salaries And Wages	$1,904,042	$1,432,073	$1,036,643
Diluted Average Shares	-	$10,285,839	$10,285,839
Basic Average Shares	-	$10,285,839	$10,285,839

Fetched: 2026-07-08

Balance Sheet (Annual)

Metric	2025-04-30	2024-04-30	2023-04-30
Assets
Net Tangible Assets	$-1,517,780	$2,258,105	$-2,333,073
Total Assets	$1,495,541	$4,009,068	$1,068,942
Total Non Current Assets	$323,538	$349,096	$365,810
Current Assets	$1,172,002	$3,659,972	$703,132
Other Current Assets	$37,310	$779	$15,499
Current Deferred Assets	$384,549	$173,749	$0
Prepaid Assets	$71,257	$49,604	$90,166
Inventory	$239,719	$145,053	$117,168
Receivables	$338,989	$1,502,904	$438,467
Loans Receivable	$309,308	$1,183,862	$0
Accounts Receivable	$29,681	$319,043	$423,909
Allowance For Doubtful Accounts Receivable	$0	$-18,255	$-16,263
Gross Accounts Receivable	$29,681	$337,297	$440,172
Cash Cash Equivalents And Short Term Investments	$100,179	$1,787,882	$41,832
Cash And Cash Equivalents	$100,179	$1,787,882	$41,832
Other Receivables	-	-	$14,558
Debt
Net Debt	$3,423	-	$513,312
Total Debt	$205,554	$612,878	$684,617
Long Term Debt And Capital Lease Obligation	$78,154	$169,608	$503,927
Long Term Debt	$60,598	$103,602	$444,292
Current Debt And Capital Lease Obligation	$127,400	$443,270	$180,689
Current Debt	$43,004	$340,590	$110,851
Liabilities
Total Liabilities Net Minority Interest	$3,013,320	$1,750,963	$3,402,014
Total Non Current Liabilities Net Minority Interest	$78,154	$169,608	$503,927
Current Liabilities	$2,935,167	$1,581,355	$2,898,087
Payables And Accrued Expenses	$2,783,022	$1,113,340	$2,692,653
Payables	$2,706,137	$1,058,420	$2,619,059
Other Payable	$317,233	$244,305	$114,352
Total Tax Payable	$0	$20,230	$4,654
Accounts Payable	$72,634	$227,270	$70,440
Equity
Common Stock Equity	$-1,517,780	$2,258,105	$-2,333,073
Total Equity Gross Minority Interest	$-1,517,780	$2,258,105	$-2,333,073
Stockholders Equity	$-1,517,780	$2,258,105	$-2,333,073
Other Equity Interest	$-28,805	$-28,805	-
Gains Losses Not Affecting Retained Earnings	$-884	$0	$0
Other Equity Adjustments	$-884	$-28,805	-
Retained Earnings	$-9,408,472	$-5,436,136	$-3,611,341
Other
Ordinary Shares Number	$10,285,839	-	-
Share Issued	$10,285,839	-	-
Tangible Book Value	$-1,517,780	$2,258,105	$-2,333,073
Invested Capital	$-1,414,178	$2,702,297	$-1,777,929
Working Capital	$-1,763,164	$2,078,617	$-2,194,955
Capital Lease Obligations	$101,952	$168,686	$129,473
Total Capitalization	$-1,457,182	$2,361,707	$-1,888,781
Additional Paid In Capital	$7,917,668	$7,720,347	$1,276,216
Capital Stock	$2,713	$2,699	$2,052
Common Stock	$2,713	$2,699	$2,052
Long Term Capital Lease Obligation	$17,556	$66,006	$59,635
Current Capital Lease Obligation	$84,396	$102,679	$69,838
Line Of Credit	$43,004	$340,590	$110,851
Current Provisions	$24,745	$24,745	$24,745
Current Accrued Expenses	$76,885	$54,920	$73,594
Dueto Related Parties Current	$2,316,270	$566,616	$2,429,613
Net PPE	$323,538	$349,096	$365,810
Accumulated Depreciation	$-529,666	$-409,387	$-307,747
Gross PPE	$853,205	$758,483	$673,557
Construction In Progress	$671	$0	-
Other Properties	$665,525	$528,394	$494,370
Machinery Furniture Equipment	$85,057	$61,404	$49,714
Buildings And Improvements	$101,952	$168,686	$129,473
Properties	$0	$0	$0
Finished Goods	$125,730	$62,696	$105,974
Work In Process	$72,990	$63,816	$0
Raw Materials	$41,000	$18,541	$11,195

Fetched: 2026-07-08

Cash Flow Statement (Annual)

Metric	2025-04-30	2024-04-30	2023-04-30
Free Cash Flow
Free Cash Flow	$-3,010,793	$-1,338,363	$-1,551,306
Operating Activities
Operating Cash Flow	$-2,825,045	$-1,244,552	$-1,383,014
Cash Flow From Continuing Operating Activities	$-2,825,045	$-1,244,552	$-1,383,014
Operating Gains Losses	-	-	$-11,426
Investing Activities
Capital Expenditure	$-185,749	$-93,812	$-168,291
Investing Cash Flow	$-257,374	$-1,277,673	$-145,288
Cash Flow From Continuing Investing Activities	$-257,374	$-1,277,673	$-145,288
Net Other Investing Changes	$-71,625	$-1,183,862	-
Financing Activities
Repurchase Of Capital Stock	$-260,847	$-2,215,707	$0
Issuance Of Capital Stock	$197,335	$6,276,785	$921,737
Financing Cash Flow	$1,395,599	$4,268,276	$1,476,881
Cash Flow From Continuing Financing Activities	$1,395,599	$4,268,276	$1,476,881
Net Other Financing Charges	$-210,799	$-173,749	-
Net Common Stock Issuance	$-63,512	$4,061,078	$921,737
Common Stock Issuance	$197,335	$6,276,785	$921,737
Other
Repayment Of Debt	$-340,590	$-110,951	$-40,274
Issuance Of Debt	$2,010,501	$491,898	$595,418
Interest Paid Supplemental Data	$6,544	$33,670	$19,383
End Cash Position	$100,179	$1,787,882	$41,832
Beginning Cash Position	$1,787,882	$41,832	$93,253
Effect Of Exchange Rate Changes	$-884	$0	-
Changes In Cash	$-1,686,820	$1,746,050	$-51,422
Common Stock Payments	$-260,847	$-2,215,707	$0
Net Issuance Payments Of Debt	$1,669,910	$380,947	$555,143
Net Long Term Debt Issuance	$1,669,910	$380,947	$555,143
Long Term Debt Payments	$-340,590	$-110,951	$-40,274
Long Term Debt Issuance	$2,010,501	$491,898	$595,418
Net PPE Purchase And Sale	$-185,749	$-93,812	$-145,288
Purchase Of PPE	$-185,749	$-93,812	$-168,291
Change In Working Capital	$-53,783	$324,738	$-307,469
Change In Other Current Liabilities	$-110,322	$-105,769	$-73,133
Change In Other Current Assets	$-58,184	$55,282	$-56,737
Change In Payables And Accrued Expense	$-79,972	$309,938	$95,767
Change In Accrued Expense	$74,664	$153,108	$121,665
Change In Payable	$-154,636	$156,830	$-25,898
Change In Account Payable	$-154,636	$156,830	$-25,898
Change In Inventory	$-94,666	$-27,885	$90,109
Change In Receivables	$289,361	$119,425	$-369,452
Changes In Account Receivables	$289,361	$104,866	$-354,894
Other Non Cash Items	$110,322	$105,769	$73,133
Asset Impairment Charge	$946,179	$13,091	$1,141
Depreciation Amortization Depletion	$144,573	$136,647	$151,283
Depreciation And Amortization	$144,573	$136,647	$151,283
Depreciation	$144,573	$136,647	$151,283
Net Income From Continuing Operations	$-3,972,335	$-1,824,796	$-1,289,677
Sale Of PPE	-	$0	$23,003
Change In Other Working Capital	-	$-26,253	$5,977
Gain Loss On Sale Of PPE	-	$0	$-11,426

Fetched: 2026-07-08